Kestra Medical Technologies (KMTS) Profit After Tax (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Profit After Tax data on file, last reported at -$38.8 million in Q2 2026.

• On a quarterly basis, Profit After Tax rose 25.39% year-over-year to -$38.8 million in Q2 2026; TTM through Apr 2026 was -$131.6 million, a 15.38% decrease from a year earlier, with the FY2026 full-year figure at -$131.6 million, down 15.64% from the prior year.
• Profit After Tax for Q2 2026 stood at -$38.8 million, down from -$34.2 million in the prior quarter.
• Over the last five years, Profit After Tax for KMTS reached as high as -$19.9 million in Q3 2024 and fell as low as -$52.1 million in Q2 2025.
• Historically, Profit After Tax has averaged -$29.0 million across 3 years, with a median of -$24.1 million in 2024.
• Across the five-year window, Profit After Tax slumped 133.59% in 2025 and rose 25.39% in 2026, its largest moves.
• Year by year, Profit After Tax stood at -$20.4 million in 2024, then slumped by 60.96% to -$32.8 million in 2025, then dropped by 18.45% to -$38.8 million in 2026.
• Per Business Quant data, the three most recent Profit After Tax figures were -$38.8 million in Q2 2026, -$34.2 million in Q1 2026, and -$32.8 million in Q4 2025.